VRCA earnings: a positive outcome, +19.5%

On May 13, 2024, Verrica Pharmaceuticals Inc. reached its earnings. The result was a positive outcome, and the stock moved +19.5% in the window around the event. It had already run +16.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.